Variability in the Performance of Nuclear Matrix Protein 22 for the Detection of Bladder Cancer

Abstract

There is a substantial degree of heterogeneity in the diagnostic performance of NMP22 applied to populations from different institutions. There is no clearly defined NMP22 cutoff but there is a continuum of risk for recurrence and progression.